Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Bolen

Showing results (31-40 of 48) with videos related to

Pageof 5
Sort By:
Nature Communications|March 24, 2016
Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cellsFlorian Rubelt, Christopher R Bolen, Helen M McGuire, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of AtezolizumabOmid Hamid, Luciana Molinero, Christopher R Bolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep SequencingJason A Vander Heiden, Panos Stathopoulos, Julian Q Zhou, et al.
Frontiers in Oncology|August 23, 2021
Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With OutcomesHussein A Abbas, Vakul Mohanty, Ruiping Wang, et al.
Clinical and Vaccine Immunology : CVI|October 31, 2014
Systems immunology reveals markers of susceptibility to West Nile virus infectionFeng Qian, Gautam Goel, Hailong Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with ImmunochemotherapyMagdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Human Pathology|April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patientsLuc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Blood|December 4, 2023
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomasStephen J Schuster, Ling-Yuh Huw, Christopher R Bolen, et al.
Pageof 5

Showing results (31-40 of 48) with videos related to

Sort By:
Pageof 5
Nature Communications|March 24, 2016
Individual heritable differences result in unique cell lymphocyte receptor repertoires of naïve and antigen-experienced cellsFlorian Rubelt, Christopher R Bolen, Helen M McGuire, et al.
Ejhaem|July 18, 2022
A prognostic model integrating PET-derived metrics and image texture analyses with clinical risk factors from GOYALale Kostakoglu, Federico Dalmasso, Paola Berchialla, et al.
Blood Advances|December 23, 2021
Pharmacodynamics and molecular correlates of response to glofitamab in relapsed/refractory non-Hodgkin lymphomaAnn-Marie E Bröske, Koorosh Korfi, Anton Belousov, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 31, 2019
Safety, Clinical Activity, and Biological Correlates of Response in Patients with Metastatic Melanoma: Results from a Phase I Trial of AtezolizumabOmid Hamid, Luciana Molinero, Christopher R Bolen, et al.
Journal of Immunology (Baltimore, Md. : 1950)|January 15, 2017
Dysregulation of B Cell Repertoire Formation in Myasthenia Gravis Patients Revealed through Deep SequencingJason A Vander Heiden, Panos Stathopoulos, Julian Q Zhou, et al.
Frontiers in Oncology|August 23, 2021
Decoupling Lineage-Associated Genes in Acute Myeloid Leukemia Reveals Inflammatory and Metabolic Signatures Associated With OutcomesHussein A Abbas, Vakul Mohanty, Ruiping Wang, et al.
Clinical and Vaccine Immunology : CVI|October 31, 2014
Systems immunology reveals markers of susceptibility to West Nile virus infectionFeng Qian, Gautam Goel, Hailong Meng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 5, 2019
Prognostic Impact of Natural Killer Cell Count in Follicular Lymphoma and Diffuse Large B-cell Lymphoma Patients Treated with ImmunochemotherapyMagdalena Klanova, Mikkel Z Oestergaard, Marek Trněný, et al.
Human Pathology|April 18, 2017
Rituximab treatment circumvents the prognostic impact of tumor-infiltrating T-cells in follicular lymphoma patientsLuc Xerri, Sarah Huet, Jeffrey M Venstrom, et al.
Blood|December 4, 2023
Loss of CD20 expression as a mechanism of resistance to mosunetuzumab in relapsed/refractory B-cell lymphomasStephen J Schuster, Ling-Yuh Huw, Christopher R Bolen, et al.
Pageof 5